Published: 30 Sep 2022 | Report Code: 10248841 | Pages: 207
Global single cell multiomics market will reach $14,369.5 million by 2031, growing by 18.6% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 89 tables and 109 figures, this 207-page report “Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software Based on Omics Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single Cell Genomics (SCG) • Single Cell Transcriptomics (SCT) • Single Cell Proteomics (SCP) • Single Cell Metabolomics (SCM) By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Research o Oncology o Cell Therapy o Immunology o Neurology o Cell Biology o Other Types of Clinical Research • Translation Research • Synthetic Biology By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Human Samples o Cancer Tissues o Stem Cells o Immune Cells o Brain Cells o Other Human Samples • Animal Samples • Microbial Samples By Workflow, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Cell Isolation and Dispensing o Fluorescence-Activated Cell Sorting (FACS) o Microfluidics o Magnetic-Activated Cell Sorting (MACS) o Random Seeding o Manual Cell Picking o Laser Capture Microdissection o Other Technologies of Single-Cell Isolation and Dispensing • Single-Cell Analysis o Polymerase Chain Reaction o Next-Generation Sequencing o Mass Cytometry o Mass Spectrometry o Other Technologies of Single-Cell Analysis By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research and Academic Laboratories • Biopharmaceutical and Biotech Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Omics Type, Workflow and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents:
1 Introduction 11 1.1 Industry Definition and Research Scope 11 1.1.1 Industry Definition 11 1.1.2 Research Scope 12 1.2 Research Methodology 15 1.2.1 Overview of Market Research Methodology 15 1.2.2 Market Assumption 16 1.2.3 Secondary Data 16 1.2.4 Primary Data 16 1.2.5 Data Filtration and Model Design 17 1.2.6 Market Size/Share Estimation 18 1.2.7 Research Limitations 19 1.3 Executive Summary 20 2 Market Overview and Dynamics 23 2.1 Market Size and Forecast 23 2.1.1 Impact of COVID-19 on World Economy 24 2.1.2 Impact of COVID-19 on the Market 28 2.2 Major Growth Drivers 30 2.3 Market Restraints and Challenges 38 2.4 Emerging Opportunities and Market Trends 41 2.5 Porter’s Fiver Forces Analysis 45 3 Segmentation of Global Market by Product Type 49 3.1 Market Overview by Product Type 49 3.2 Instruments 51 3.3 Consumables 52 3.4 Software 53 4 Segmentation of Global Market by Omics Type 54 4.1 Market Overview by Omics Type 54 4.2 Single Cell Genomics (SCG) 56 4.3 Single Cell Transcriptomics (SCT) 57 4.4 Single Cell Proteomics (SCP) 58 4.5 Single Cell Metabolomics (SCM) 59 5 Segmentation of Global Market by Application 60 5.1 Market Overview by Application 60 5.2 Clinical Research 62 5.2.1 Oncology 64 5.2.2 Cell Therapy 65 5.2.3 Immunology 66 5.2.4 Neurology 67 5.2.5 Cell Biology 68 5.2.6 Other Types of Clinical Research 69 5.3 Translation Research 70 5.4 Synthetic Biology 71 6 Segmentation of Global Market by Sample Type 72 6.1 Market Overview by Sample Type 72 6.2 Human Samples 74 6.2.1 Cancer Tissues 76 6.2.2 Stem Cells 77 6.2.3 Immune Cells 78 6.2.4 Brain Cells 79 6.2.5 Other Human Samples 80 6.3 Animal Samples 81 6.4 Microbial Samples 82 7 Segmentation of Global Market by Workflow 83 7.1 Market Overview by Workflow 83 7.2 Single-Cell Isolation and Dispensing 85 7.2.1 Fluorescence-Activated Cell Sorting (FACS) 87 7.2.2 Microfluidics 88 7.2.3 Magnetic-Activated Cell Sorting (MACS) 89 7.2.4 Random Seeding 90 7.2.5 Manual Cell Picking 91 7.2.6 Laser Capture Microdissection 92 7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 93 7.3 Single-Cell Analysis 94 7.3.1 Polymerase Chain Reaction 96 7.3.2 Next-Generation Sequencing 97 7.3.3 Mass Cytometry 98 7.3.4 Mass Spectrometry 99 7.3.5 Other Technologies of Single-Cell Analysis 100 8 Segmentation of Global Market by End User 101 8.1 Market Overview by End User 101 8.2 Research and Academic Laboratories 103 8.3 Biopharmaceutical and Biotech Companies 104 8.4 Contract Research Organizations (CROs) 105 8.5 Other End Users 106 9 Segmentation of Global Market by Region 107 9.1 Geographic Market Overview 2021-2031 107 9.2 North America Market 2021-2031 by Country 111 9.2.1 Overview of North America Market 111 9.2.2 U.S. 115 9.2.3 Canada 118 9.2.4 Mexico 120 9.3 European Market 2021-2031 by Country 122 9.3.1 Overview of European Market 122 9.3.2 Germany 126 9.3.3 U.K. 128 9.3.4 France 130 9.3.5 Spain 132 9.3.6 Italy 134 9.3.7 Netherlands 136 9.3.8 Rest of European Market 138 9.4 Asia-Pacific Market 2021-2031 by Country 140 9.4.1 Overview of Asia-Pacific Market 140 9.4.2 Japan 144 9.4.3 China 147 9.4.4 Australia 149 9.4.5 India 151 9.4.6 South Korea 153 9.4.7 Rest of APAC Region 155 9.5 South America Market 2021-2031 by Country 157 9.5.1 Argentina 160 9.5.2 Brazil 162 9.5.3 Chile 164 9.5.4 Rest of South America Market 166 9.6 MEA Market 2021-2031 by Country 167 9.6.1 UAE 170 9.6.2 Saudi Arabia 172 9.6.3 South Africa 174 9.6.4 Other National Markets 176 10 Competitive Landscape 177 10.1 Overview of Key Vendors 177 10.2 New Product Launch, Partnership, Investment, and M&A 181 10.3 Company Profiles 182 10x Genomics, Inc. 182 1CellBio, Inc. 184 Becton, Dickinson and Company 185 Berkeley Lights, Inc. 186 BGI Genomics Co., Ltd. 187 Bio-Rad Laboratories, Inc. 188 Bio-Techne Corporation 189 BioTuring, Inc. 190 Danaher Corporation (Cytiva Life Sciences) 191 Dolomite Bio 192 Fluidigm Corporation 193 Fluxion Biosciences 194 Illimina, Inc 195 Mission Bio, Inc. 196 Namocell, Inc. 197 NanoString Technologies, Inc. 198 Parse Biosciences, Inc. 199 Proteona 200 Qiagen N.V. 201 RareCyte, Inc. 202 Scipio Biosciences SAS 203 Shilps Sciences 204 Takara Bio Inc. (Takara Holdings) 205 Thermo Fisher Scientific Inc. 206 RELATED REPORTS 207
List of Tables:
Table 1. Snapshot of Global Single Cell Multiomics Market in Balanced Perspective, 2021-2031 21 Table 2. World Economic Outlook, 2021-2031 25 Table 3. World Economic Outlook, 2021-2023 26 Table 4. Comparison of Rare Disease in Different Countries 35 Table 5. World Health Spending by Region, $ bn, 2013-2020 37 Table 6. Main Product Trends and Market Opportunities in Global Single Cell Multiomics Market 41 Table 7. Global Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 49 Table 8. Global Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 54 Table 9. Global Single Cell Multiomics Market by Application, 2021-2031, $ mn 60 Table 10. Global Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 63 Table 11. Global Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 72 Table 12. Global Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 75 Table 13. Global Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 83 Table 14. Global Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 86 Table 15. Global Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 95 Table 16. Global Single Cell Multiomics Market by End User, 2021-2031, $ mn 101 Table 17. Global Single Cell Multiomics Market by Region, 2021-2031, $ mn 108 Table 18. Leading National Single Cell Multiomics Market, 2021 and 2031, $ mn 110 Table 19. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 113 Table 20. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 117 Table 21. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 117 Table 22. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 117 Table 23. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 119 Table 24. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 119 Table 25. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 119 Table 26. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 121 Table 27. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 121 Table 28. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 121 Table 29. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn 125 Table 30. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 127 Table 31. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 127 Table 32. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn 127 Table 33. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 129 Table 34. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 129 Table 35. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn 129 Table 36. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 131 Table 37. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 131 Table 38. France Single Cell Multiomics Market by End User, 2021-2031, $ mn 131 Table 39. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 133 Table 40. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 133 Table 41. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn 133 Table 42. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 135 Table 43. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 135 Table 44. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn 135 Table 45. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 137 Table 46. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 137 Table 47. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn 137 Table 48. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn 139 Table 49. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn 142 Table 50. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 146 Table 51. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 146 Table 52. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn 146 Table 53. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 148 Table 54. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 148 Table 55. China Single Cell Multiomics Market by End User, 2021-2031, $ mn 148 Table 56. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 150 Table 57. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 150 Table 58. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn 150 Table 59. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 152 Table 60. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 152 Table 61. India Single Cell Multiomics Market by End User, 2021-2031, $ mn 152 Table 62. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 154 Table 63. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 154 Table 64. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn 154 Table 65. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 156 Table 66. South America Single Cell Multiomics Market by Country, 2021-2031, $ mn 159 Table 67. Argentina Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 161 Table 68. Argentina Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 161 Table 69. Argentina Single Cell Multiomics Market by End User, 2021-2031, $ mn 161 Table 70. Brazil Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 163 Table 71. Brazil Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 163 Table 72. Brazil Single Cell Multiomics Market by End User, 2021-2031, $ mn 163 Table 73. Chile Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 165 Table 74. Chile Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 165 Table 75. Chile Single Cell Multiomics Market by End User, 2021-2031, $ mn 165 Table 76. MEA Single Cell Multiomics Market by Country, 2021-2031, $ mn 169 Table 77. UAE Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 171 Table 78. UAE Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 171 Table 79. UAE Single Cell Multiomics Market by End User, 2021-2031, $ mn 171 Table 80. Saudi Arabia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 173 Table 81. Saudi Arabia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 173 Table 82. Saudi Arabia Single Cell Multiomics Market by End User, 2021-2031, $ mn 173 Table 83. South Africa Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 175 Table 84. South Africa Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 175 Table 85. South Africa Single Cell Multiomics Market by End User, 2021-2031, $ mn 175 Table 86. Breakdown of World Market by Key Vendor, 2020, % 179 Table 87. 10x Genomics, Inc.: Company Snapshot 182 Table 88. 10x Genomics, Inc.: Business Segmentation 183 Table 89. 10x Genomics, Inc.: Product Portfolio 183
List of Figures:
Figure 1. Research Method Flow Chart 15 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20 Figure 4. Global Single Cell Multiomics Market, 2021-2031, $ mn 23 Figure 5. Impact of COVID-19 on Business 28 Figure 6. Primary Drivers and Impact Factors of Global Single Cell Multiomics Market 30 Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 33 Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 34 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36 Figure 11. Primary Restraints and Impact Factors of Global Single Cell Multiomics Market 38 Figure 12. Investment Opportunity Analysis 42 Figure 13. Porter’s Fiver Forces Analysis of Global Single Cell Multiomics Market 45 Figure 14. Breakdown of Global Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 50 Figure 15. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 50 Figure 16. Global Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 51 Figure 17. Global Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 52 Figure 18. Global Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 53 Figure 19. Breakdown of Global Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 55 Figure 20. Global Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 55 Figure 21. Global Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 56 Figure 22. Global Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 57 Figure 23. Global Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 58 Figure 24. Global Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 59 Figure 25. Breakdown of Global Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 61 Figure 26. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 61 Figure 27. Global Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 62 Figure 28. Global Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 64 Figure 29. Global Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 65 Figure 30. Global Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 66 Figure 31. Global Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 67 Figure 32. Global Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 68 Figure 33. Global Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 69 Figure 34. Global Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 70 Figure 35. Global Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 71 Figure 36. Breakdown of Global Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 73 Figure 37. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 73 Figure 38. Global Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 74 Figure 39. Global Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 76 Figure 40. Global Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 77 Figure 41. Global Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 78 Figure 42. Global Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 79 Figure 43. Global Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 80 Figure 44. Global Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 81 Figure 45. Global Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 82 Figure 46. Breakdown of Global Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 84 Figure 47. Global Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 84 Figure 48. Global Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 85 Figure 49. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 87 Figure 50. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 88 Figure 51. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 89 Figure 52. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 90 Figure 53. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 91 Figure 54. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 92 Figure 55. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 93 Figure 56. Global Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 94 Figure 57. Global Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 96 Figure 58. Global Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 97 Figure 59. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 98 Figure 60. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 99 Figure 61. Global Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 100 Figure 62. Breakdown of Global Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 101 Figure 63. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 102 Figure 64. Global Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 103 Figure 65. Global Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 104 Figure 66. Global Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 105 Figure 67. Global Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 106 Figure 68. Global Market Snapshot by Region 107 Figure 69. Geographic Spread of Worldwide Single Cell Multiomics Market, 2021-2031, % of Sales Revenue 108 Figure 70. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 109 Figure 71. North American Single Cell Multiomics Market, 2021-2031, $ mn 112 Figure 72. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 113 Figure 73. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 114 Figure 74. U.S. Single Cell Multiomics Market, 2021-2031, $ mn 116 Figure 75. Canada Single Cell Multiomics Market, 2021-2031, $ mn 118 Figure 76. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn 120 Figure 77. European Single Cell Multiomics Market, 2021-2031, $ mn 123 Figure 78. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 124 Figure 79. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 125 Figure 80. Single Cell Multiomics Market in Germany, 2021-2031, $ mn 126 Figure 81. Single Cell Multiomics Market in U.K., 2021-2031, $ mn 128 Figure 82. Single Cell Multiomics Market in France, 2021-2031, $ mn 130 Figure 83. Single Cell Multiomics Market in Spain, 2021-2031, $ mn 132 Figure 84. Single Cell Multiomics Market in Italy, 2021-2031, $ mn 134 Figure 85. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn 136 Figure 86. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn 138 Figure 87. Asia-Pacific Single Cell Multiomics Market, 2021-2031, $ mn 141 Figure 88. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 141 Figure 89. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 143 Figure 90. Single Cell Multiomics Market in Japan, 2021-2031, $ mn 145 Figure 91. Single Cell Multiomics Market in China, 2021-2031, $ mn 147 Figure 92. Single Cell Multiomics Market in Australia, 2021-2031, $ mn 149 Figure 93. Single Cell Multiomics Market in India, 2021-2031, $ mn 151 Figure 94. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn 153 Figure 95. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn 155 Figure 96. South America Single Cell Multiomics Market, 2021-2031, $ mn 158 Figure 97. Breakdown of South America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 158 Figure 98. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 159 Figure 99. Single Cell Multiomics Market in Argentina, 2021-2031, $ mn 160 Figure 100. Single Cell Multiomics Market in Brazil, 2021-2031, $ mn 162 Figure 101. Single Cell Multiomics Market in Chile, 2021-2031, $ mn 164 Figure 102. Single Cell Multiomics Market in Rest of South America, 2021-2031, $ mn 166 Figure 103. Single Cell Multiomics Market in Middle East and Africa (MEA), 2021-2031, $ mn 168 Figure 104. Breakdown of MEA Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 168 Figure 105. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 169 Figure 106. Single Cell Multiomics Market in UAE, 2021-2031, $ mn 170 Figure 107. Single Cell Multiomics Market in Saudi Arabia, 2021-2031, $ mn 172 Figure 108. Single Cell Multiomics Market in South Africa, 2021-2031, $ mn 174 Figure 109. Growth Stage of Global Single Cell Multiomics Industry over the Forecast Period 177
Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)